- About About
-
Medical
Medical
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
-
Advocacy
Advocacy
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
-
Policy
Policy
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- Join Join
-
-
Patient Safety Drives California Medical Association's Position on Cannabis
Last month, the California Medical Association (CMA) adopted an official position calling for the legalization and regulation of cannabis. According to an editorial in the Sacramento Bee by CMA president-elect Dr. Paul Phinney and CMA speaker of the house Dr. Luther Cobb, the adoption of this policy by the largest statewide physician organization in America is primarily a result of concern for patient safety as the present system of medical cannabis is "flawed, contradictory, and dangerously detached from scientific evidence...Until [it] is legalized, we cannot regulate it in a way that's safe for patient use."
Citing both a "lack of comprehensive scientific and medical research" as well as a fear of federal prosecution under the current state of cannabis, the CMA believes that by removing cannabis from Schedule I and allowing for research and regulation, they are "watching out for the good of the public health and the safety of [their] patients." The organization's goal in calling for legalization is not to make the drug more widely available but instead to "create a strict regulatory system, ultimately limiting distribution and standardizing medical cannabis."
Hopefully for medical cannabis patients and advocates, the trend of seeing medical cannabis as a health issue rather than a legal or law enforcement one will continue to gain support from other public health organizations as the impact of the CMA's new policy continues to spread.
Share